116 results
8-K
KA
Kineta Inc
6 Feb 19
Departure of Directors or Certain Officers
8:00am
responsibility at Novartis (NYSE:NVS) from February 2006 to May 2014, including Vice President, Global Head Lung/Cystic Fibrosis. From August 2003 … to February 2006, he was Business Unit Lead for Cardiovascular Medicine at Abbott (NYSE:ABT). Dr. Dulac held several roles of increasing responsibility
8-K
KA
Kineta Inc
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
of increasing responsibility at Merck & Co., Inc. In addition to having previously served as a director of Onyx Pharmaceuticals and NPS Pharmaceuticals, Dr. Coles … & Co., Inc. where he held roles of increasing responsibility, including Vice President and Controller of the U.S. Human Health division and Controller
8-K
KA
Kineta Inc
24 May 19
Departure of Directors or Certain Officers
4:06pm
. Larson held various positions of increasing responsibility within Northern Power Systems, most recently as Vice President and Chief Accounting
8-K
nea1w
29 Jun 23
Kineta to Receive $5 Million Milestone Payment from Merck
7:01am
8-K
c4w75ypuqy
11 Feb 19
Departure of Directors or Certain Officers
5:03pm
8-K
EX-99.1
dv2412 m130c5
29 Jun 23
Kineta to Receive $5 Million Milestone Payment from Merck
7:01am
DEFA14A
7ehxt0od tcgjxg0azlv
13 May 19
Additional proxy soliciting materials
8:02am
8-K
EX-10.1
ddea48241
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-2.2
njrac9ur
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
8-K/A
kz78nm dgmvx3px
13 May 19
Departure of Directors or Certain Officers
5:28pm
8-K
EX-99.1
ou5 gkxpec4jq
28 Jun 23
Departure of Directors or Certain Officers
7:00am
8-K
lrvh7xtdd tir01b1v5r
13 May 19
Departure of Directors or Certain Officers
8:00am
425
EX-2.2
7fqtm74r oaa2r2lpq1
24 Aug 20
Business combination disclosure
5:28pm
S-4
EX-10.16
svxx1ms t7
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
EX-10.1
y983s4dti s08quomc10
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm